Clinical Characteristics and Treatment Outcome of 485 Patients with Nonfunctioning Pituitary Macroadenomas

被引:55
作者
Vargas, Guadalupe [1 ]
Gonzalez, Baldomero [1 ,2 ]
Ramirez, Claudia [1 ,2 ]
Ferreira, Aldo [1 ]
Espinosa, Etual [1 ]
Mendoza, Victoria [1 ]
Guinto, Gerardo [2 ,3 ]
Lopez-Felix, Blas [3 ]
Zepeda, Erick [3 ]
Mercado, Moises [1 ,2 ]
机构
[1] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Hosp Especialidades, Endocrinol Serv,Expt Endocrinol Unit, Mexico City, DF, Mexico
[2] Amer British Hosp Neurol Ctr, Mexico City, DF, Mexico
[3] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Hosp Especialidades, Dept Neurosurg, Mexico City, DF, Mexico
关键词
FOLLOW-UP; NATURAL-HISTORY; ADENOMAS; EXPRESSION; TUMORS; SURGERY; SOMATOTROPINOMAS; RADIOTHERAPY; CABERGOLINE; MANAGEMENT;
D O I
10.1155/2015/756069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Nonfunctioning pituitary adenomas (NFPAs) are the most common benign lesions of the pituitary gland. Objective. To describe our experience with the management of NFPA. Study Design and Methods. Retrospective evaluation of NFPA patients managed between 2008 and 2013. We analyzed data regarding clinical presentation, imaging diagnosis, hormonal status, surgical, radiotherapeutic, and pharmacological treatment, and outcome. Results. 485 patients (54% men, mean age 53 +/- 14 years) were followed for a median of 6.5 years. Visual field abnormalities and headaches were the presenting complaints in 87% and 66%, respectively. The diagnosis of NFPA was made incidentally in 6.2%, and 8% presented with clinical evidence of apoplexy. All patients harbored macroadenomas, with a median volume of 10306 mm(3) ; 57.9% had supra-or parasellar invasion and 19.6% had tumors larger than 4 cm. Central hypothyroidism, hypogonadism, and hypocortisolism were present in 47.2%, 35.9%, and 27.4%, respectively. Surgical resection was performed at least once in 85.7%. Tumor persistence was documented in 27% and was related to the size and invasiveness of the lesion. In selected cases, radiotherapy proved to be effective in controlling or preventing tumor growth. Conclusions. The diagnosis and treatment of NFPA are complex and require a multidisciplinary approach.
引用
收藏
页数:7
相关论文
共 36 条
[21]   Minor tumour shrinkage in nonfunctioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline [J].
Lohmann T. ;
Trantakis C. ;
Biesold M. ;
Prothmann S. ;
Guenzel S. ;
Schober R. ;
Paschke R. .
Pituitary, 2001, 4 (3) :173-178
[22]   RECOVERY OF VISUAL AND ENDOCRINE FUNCTION FOLLOWING TRANSSPHENOIDAL SURGERY OF LARGE NONFUNCTIONING PITUITARY-ADENOMAS [J].
MARAZUELA, M ;
ASTIGARRAGA, B ;
VICENTE, A ;
ESTRADA, J ;
CUERDA, C ;
GARCIAURIA, J ;
LUCAS, T .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1994, 17 (09) :703-707
[23]   Natural History of Nonfunctioning Pituitary Adenomas and Incidentalomas: A Systematic Review and Metaanalysis [J].
Merce Fernandez-Balsells, M. ;
Murad, Mohammad Hassan ;
Barwise, Amelia ;
Gallegos-Orozco, Juan F. ;
Paul, Anu ;
Lane, Melanie A. ;
Lampropulos, Julianna F. ;
Natividad, Ines ;
Perestelo-Perez, Lilisbeth ;
Ponce de Leon-Lovaton, Paula G. ;
Erwin, Patricia J. ;
Carey, Jantey ;
Montori, Victor M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) :905-912
[24]   Nonfunctioning pituitary tumors and pituitary incidentalomas [J].
Molitch, Mark E. .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2008, 37 (01) :151-+
[25]   The epidemiology of endocrine tumours [J].
Monson, JP .
ENDOCRINE-RELATED CANCER, 2000, 7 (01) :29-36
[26]   Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas - a study on 721 patients [J].
Nomikos, P ;
Ladar, C ;
Fahlbusch, R ;
Buchfelder, M .
ACTA NEUROCHIRURGICA, 2004, 146 (01) :27-35
[27]   Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: Comparison with the effectiveness of cabergoline treatment [J].
Pivonello, R ;
Matrone, C ;
Filippella, M ;
Cavallo, LM ;
Di Somma, C ;
Cappabianca, P ;
Colao, A ;
Annunziato, L ;
Lombardi, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1674-1683
[28]   Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in Nonfunctioning Pituitary Adenomas: A High Throughput TMA, Immunohistochemical Study [J].
Ramirez, Claudia ;
Cheng, Sonia ;
Vargas, Guadalupe ;
Asa, Sylvia L. ;
Ezzat, Shereen ;
Gonzalez, Baldomero ;
Cabrera, Lourdes ;
Guinto, Gerardo ;
Mercado, Moises .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05) :1745-1751
[29]   Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma? [J].
Reddy, Raghava ;
Cudlip, Simon ;
Byrne, James V. ;
Karavitaki, Niki ;
Wass, John A. H. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (05) :739-744
[30]   Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis [J].
Roelfsema, Ferdinand ;
Biermasz, Nienke R. ;
Pereira, Alberto M. .
PITUITARY, 2012, 15 (01) :71-83